GILD |
Gilead Sciences, Inc. |
111.79B |
9.25% |
|
|
|
|
|
89.70 |
1.21% |
25.32% |
34.87% |
---|
VRTX |
Vertex Pharmaceuticals Incorporated |
115.72B |
7.91% |
|
|
|
|
|
449.35 |
-0.42% |
48.20% |
93.89% |
---|
AMGN |
Amgen Inc. |
156.10B |
7.82% |
|
|
|
|
|
290.41 |
0.88% |
51.85% |
91.97% |
---|
REGN |
Regeneron Pharmaceuticals, Inc. |
80.97B |
6.45% |
|
|
|
|
|
749.23 |
0.79% |
30.89% |
66.05% |
---|
AZN |
AstraZeneca PLC |
197.76B |
4.42% |
|
|
|
|
|
63.78 |
0.92% |
28.18% |
63.14% |
---|
ALNY |
Alnylam Pharmaceuticals, Inc. |
31.90B |
3.68% |
|
|
|
|
|
247.35 |
-0.58% |
45.24% |
29.39% |
---|
BIIB |
Biogen Inc. |
23.02B |
2.69% |
|
|
|
|
|
157.98 |
1.27% |
30.94% |
44.39% |
---|
ILMN |
Illumina, Inc. |
21.61B |
2.29% |
|
|
|
|
|
136.28 |
3.49% |
39.33% |
25.43% |
---|
MRNA |
Moderna, Inc. |
14.52B |
2.10% |
|
|
|
|
|
37.73 |
2.14% |
86.28% |
95.30% |
---|
ARGX |
argenx SE |
35.52B |
1.78% |
|
|
|
|
|
588.46 |
-0.57% |
28.29% |
24.20% |
---|
SMMT |
Summit Therapeutics Inc. |
13.82B |
1.61% |
|
|
|
|
|
18.76 |
0.72% |
74.87% |
6.08% |
---|
SNY |
Sanofi |
120.29B |
1.59% |
|
|
|
|
|
47.98 |
0.42% |
26.56% |
50.15% |
---|
UTHR |
United Therapeutics Corporation |
16.42B |
1.55% |
|
|
|
|
|
367.84 |
0.96% |
34.51% |
79.47% |
---|
VTRS |
Viatris Inc. |
15.82B |
1.40% |
|
|
|
|
|
13.26 |
0.95% |
27.53% |
12.10% |
---|
BMRN |
BioMarin Pharmaceutical Inc. |
12.04B |
1.33% |
|
|
|
|
|
63.18 |
0.99% |
31.41% |
29.32% |
---|
INCY |
Incyte Corporation |
13.51B |
1.26% |
|
|
|
|
|
70.13 |
-1.29% |
53.79% |
75.08% |
---|
PCVX |
Vaxcyte, Inc. |
11.16B |
1.26% |
|
|
|
|
|
89.57 |
4.19% |
43.84% |
11.05% |
---|
SRPT |
Sarepta Therapeutics, Inc. |
10.55B |
1.24% |
|
|
|
|
|
110.50 |
-0.32% |
42.29% |
8.39% |
---|
INSM |
Insmed Incorporated |
13.14B |
1.23% |
|
|
|
|
|
73.48 |
1.11% |
53.30% |
9.61% |
---|
RPRX |
Royalty Pharma plc |
11.78B |
1.22% |
|
|
|
|
|
26.51 |
1.09% |
68.82% |
48.67% |
---|
NBIX |
Neurocrine Biosciences, Inc. |
12.62B |
1.17% |
|
|
|
|
|
124.67 |
1.12% |
26.16% |
22.52% |
---|
BNTX |
BioNTech SE |
25.68B |
1.11% |
|
|
|
|
|
107.13 |
4.89% |
44.27% |
52.38% |
---|
MEDP |
Medpace Holdings, Inc. |
10.58B |
1.02% |
|
|
|
|
|
340.54 |
4.43% |
36.64% |
33.77% |
---|
BGNE |
BeiGene, Ltd. |
21.45B |
0.96% |
|
|
|
|
|
192.91 |
-0.69% |
40.40% |
31.73% |
---|
ROIV |
Roivant Sciences Ltd. |
8.62B |
0.87% |
|
|
|
|
|
11.85 |
3.09% |
38.42% |
30.06% |
---|
EXEL |
Exelixis, Inc. |
9.91B |
0.81% |
|
|
|
|
|
34.71 |
0.17% |
31.60% |
22.28% |
---|
ITCI |
Intra-Cellular Therapies, Inc. |
9.06B |
0.81% |
|
|
|
|
|
85.51 |
-0.16% |
31.31% |
9.80% |
---|
RVMD |
Revolution Medicines, Inc. |
9.62B |
0.80% |
|
|
|
|
|
57.20 |
0.23% |
86.08% |
65.80% |
---|
ASND |
Ascendis Pharma A/S |
7.38B |
0.75% |
|
|
|
|
|
123.43 |
-0.76% |
30.88% |
11.23% |
---|
JAZZ |
Jazz Pharmaceuticals plc |
7.54B |
0.69% |
|
|
|
|
|
124.78 |
4.65% |
28.93% |
49.79% |
---|
HALO |
Halozyme Therapeutics, Inc. |
5.77B |
0.64% |
|
|
|
|
|
45.32 |
-0.96% |
52.79% |
56.19% |
---|
CYTK |
Cytokinetics, Incorporated |
5.67B |
0.61% |
|
|
|
|
|
48.07 |
-3.59% |
65.93% |
11.94% |
---|
IONS |
Ionis Pharmaceuticals, Inc. |
5.42B |
0.59% |
|
|
|
|
|
34.32 |
-3.07% |
45.46% |
42.80% |
---|
NUVL |
Nuvalent, Inc. |
6.65B |
0.55% |
|
|
|
|
|
93.54 |
2.60% |
41.97% |
24.48% |
---|
RNA |
Avidity Biosciences, Inc. |
5.15B |
0.53% |
|
|
|
|
|
43.20 |
-1.04% |
70.29% |
13.46% |
---|
BPMC |
Blueprint Medicines Corporation |
6.16B |
0.52% |
|
|
|
|
|
96.95 |
2.26% |
50.31% |
19.86% |
---|
KRYS |
Krystal Biotech, Inc. |
5.22B |
0.51% |
|
|
|
|
|
181.56 |
1.94% |
41.44% |
35.92% |
---|
RARE |
Ultragenyx Pharmaceutical Inc. |
4.30B |
0.49% |
|
|
|
|
|
46.55 |
0.32% |
50.87% |
21.11% |
---|
MDGL |
Madrigal Pharmaceuticals, Inc. |
7.05B |
0.47% |
|
|
|
|
|
323.37 |
1.98% |
60.10% |
14.66% |
---|
BBIO |
BridgeBio Pharma, Inc. |
4.42B |
0.46% |
|
|
|
|
|
23.41 |
1.61% |
136.71% |
95.19% |
---|
ACLX |
Arcellx, Inc. |
4.76B |
0.46% |
|
|
|
|
|
88.01 |
0.91% |
67.52% |
40.22% |
---|
CRNX |
Crinetics Pharmaceuticals, Inc. |
5.30B |
0.46% |
|
|
|
|
|
57.20 |
2.02% |
61.71% |
32.45% |
---|
IMVT |
Immunovant, Inc. |
3.90B |
0.44% |
|
|
|
|
|
26.56 |
1.47% |
34.00% |
56.52% |
---|
ALKS |
Alkermes plc |
4.48B |
0.44% |
|
|
|
|
|
27.68 |
-0.84% |
36.43% |
56.97% |
---|
AXSM |
Axsome Therapeutics, Inc. |
4.73B |
0.43% |
|
|
|
|
|
97.67 |
3.25% |
80.47% |
79.31% |
---|
IBRX |
ImmunityBio, Inc. |
3.51B |
0.43% |
|
|
|
|
|
5.04 |
3.33% |
99.23% |
16.24% |
---|
CRSP |
CRISPR Therapeutics AG |
3.95B |
0.42% |
|
|
|
|
|
46.24 |
-2.17% |
58.15% |
26.37% |
---|
DNLI |
Denali Therapeutics Inc. |
3.51B |
0.40% |
|
|
|
|
|
24.37 |
-0.20% |
80.73% |
64.16% |
---|
ADMA |
ADMA Biologics, Inc. |
5.05B |
0.38% |
|
|
|
|
|
21.37 |
0.00% |
47.47% |
4.66% |
---|
LEGN |
Legend Biotech Corporation |
7.22B |
0.37% |
|
|
|
|
|
39.37 |
-1.93% |
65.33% |
48.62% |
---|
MRUS |
Merus N.V. |
3.07B |
0.36% |
|
|
|
|
|
44.91 |
4.61% |
71.47% |
24.99% |
---|
FOLD |
Amicus Therapeutics, Inc. |
2.83B |
0.34% |
|
|
|
|
|
9.47 |
-1.25% |
42.55% |
39.59% |
---|
IOVA |
Iovance Biotherapeutics, Inc. |
2.52B |
0.33% |
|
|
|
|
|
8.26 |
1.41% |
75.07% |
11.76% |
---|
APLS |
Apellis Pharmaceuticals, Inc. |
3.41B |
0.33% |
|
|
|
|
|
27.40 |
-0.33% |
60.86% |
18.14% |
---|
EWTX |
Edgewise Therapeutics, Inc. |
3.05B |
0.32% |
|
|
|
|
|
32.24 |
0.90% |
106.11% |
26.75% |
---|
KYMR |
Kymera Therapeutics, Inc. |
2.85B |
0.32% |
|
|
|
|
|
44.02 |
-0.08% |
60.42% |
36.81% |
---|
XENE |
Xenon Pharmaceuticals Inc. |
3.06B |
0.32% |
|
|
|
|
|
40.09 |
1.90% |
33.88% |
13.54% |
---|
PTCT |
PTC Therapeutics, Inc. |
3.33B |
0.31% |
|
|
|
|
|
43.15 |
2.82% |
71.55% |
16.62% |
---|
DYN |
Dyne Therapeutics, Inc. |
3.03B |
0.31% |
|
|
|
|
|
29.81 |
-0.60% |
82.63% |
11.91% |
---|
RYTM |
Rhythm Pharmaceuticals, Inc. |
3.65B |
0.30% |
|
|
|
|
|
59.31 |
-0.08% |
49.37% |
32.30% |
---|
PTGX |
Protagonist Therapeutics, Inc. |
2.47B |
0.28% |
|
|
|
|
|
41.38 |
1.80% |
63.50% |
25.80% |
---|
JANX |
Janux Therapeutics, Inc. |
2.44B |
0.28% |
|
|
|
|
|
46.58 |
-4.89% |
106.28% |
41.96% |
---|
GH |
Guardant Health, Inc. |
3.78B |
0.27% |
|
|
|
|
|
30.57 |
-0.36% |
53.98% |
28.48% |
---|
AGIO |
Agios Pharmaceuticals, Inc. |
3.17B |
0.26% |
|
|
|
|
|
55.64 |
1.86% |
53.89% |
65.61% |
---|
VCYT |
Veracyte, Inc. |
3.04B |
0.26% |
|
|
|
|
|
39.20 |
-0.01% |
59.76% |
24.09% |
---|
VERA |
Vera Therapeutics, Inc. |
3.00B |
0.26% |
|
|
|
|
|
47.30 |
3.39% |
52.84% |
9.07% |
---|
GERN |
Geron Corporation |
2.42B |
0.25% |
|
|
|
|
|
4.00 |
0.25% |
53.33% |
7.87% |
---|
IDYA |
IDEAYA Biosciences, Inc. |
2.31B |
0.25% |
|
|
|
|
|
26.76 |
4.78% |
96.69% |
56.95% |
---|
AMPH |
Amphastar Pharmaceuticals, Inc. |
2.14B |
0.25% |
|
|
|
|
|
44.60 |
1.16% |
71.38% |
53.47% |
---|
ARWR |
Arrowhead Pharmaceuticals, Inc. |
2.32B |
0.25% |
|
|
|
|
|
18.64 |
-0.40% |
71.34% |
67.73% |
---|
TWST |
Twist Bioscience Corporation |
2.48B |
0.25% |
|
|
|
|
|
42.35 |
3.02% |
66.19% |
26.33% |
---|
APGE |
Apogee Therapeutics, Inc. |
2.56B |
0.25% |
|
|
|
|
|
43.79 |
-2.79% |
64.40% |
45.96% |
---|
ACAD |
ACADIA Pharmaceuticals Inc. |
2.71B |
0.24% |
|
|
|
|
|
16.26 |
-0.06% |
60.49% |
33.75% |
---|
SRRK |
Scholar Rock Holding Corporation |
2.54B |
0.24% |
|
|
|
|
|
27.17 |
-2.48% |
102.58% |
25.07% |
---|
VRNA |
Verona Pharma plc |
3.15B |
0.24% |
|
|
|
|
|
38.50 |
-0.90% |
56.78% |
9.25% |
---|
KROS |
Keros Therapeutics, Inc. |
2.21B |
0.23% |
|
|
|
|
|
54.57 |
0.79% |
60.94% |
32.74% |
---|
VCEL |
Vericel Corporation |
2.80B |
0.22% |
|
|
|
|
|
56.81 |
-0.79% |
60.64% |
22.42% |
---|
GPCR |
Structure Therapeutics Inc. |
1.78B |
0.22% |
|
|
|
|
|
31.09 |
-4.97% |
82.05% |
11.64% |
---|
SWTX |
SpringWorks Therapeutics, Inc. |
2.72B |
0.22% |
|
|
|
|
|
36.57 |
-2.32% |
55.76% |
21.42% |
---|
AKRO |
Akero Therapeutics, Inc. |
2.14B |
0.21% |
|
|
|
|
|
30.63 |
-0.02% |
43.68% |
15.24% |
---|
LGND |
Ligand Pharmaceuticals Incorporated |
2.20B |
0.21% |
|
|
|
|
|
116.44 |
4.37% |
47.44% |
37.75% |
---|
HRMY |
Harmony Biosciences Holdings, Inc. |
1.89B |
0.20% |
|
|
|
|
|
33.07 |
0.85% |
63.15% |
56.95% |
---|
MYGN |
Myriad Genetics, Inc. |
1.37B |
0.20% |
|
|
|
|
|
15.06 |
-1.57% |
53.90% |
60.61% |
---|
MIRM |
Mirum Pharmaceuticals, Inc. |
2.10B |
0.19% |
|
|
|
|
|
43.73 |
0.09% |
58.22% |
34.06% |
---|
RXRX |
Recursion Pharmaceuticals, Inc. |
1.63B |
0.19% |
|
|
|
|
|
5.83 |
-3.56% |
84.01% |
28.32% |
---|
SUPN |
Supernus Pharmaceuticals, Inc. |
1.97B |
0.19% |
|
|
|
|
|
35.76 |
-1.00% |
36.92% |
35.04% |
---|
MNKD |
MannKind Corporation |
1.90B |
0.19% |
|
|
|
|
|
6.88 |
-0.07% |
47.11% |
30.96% |
---|
WVE |
Wave Life Sciences Ltd. |
2.23B |
0.19% |
|
|
|
|
|
14.61 |
2.45% |
73.15% |
2.20% |
---|
ARVN |
Arvinas, Inc. |
1.72B |
0.19% |
|
|
|
|
|
24.97 |
10.06% |
85.49% |
40.30% |
---|
BEAM |
Beam Therapeutics Inc. |
1.98B |
0.18% |
|
|
|
|
|
23.97 |
-2.14% |
80.79% |
73.94% |
---|
NVCR |
NovoCure Limited |
1.84B |
0.18% |
|
|
|
|
|
17.00 |
0.83% |
98.20% |
40.28% |
---|
OCUL |
Ocular Therapeutix, Inc. |
1.35B |
0.18% |
|
|
|
|
|
8.60 |
-2.11% |
83.91% |
29.91% |
---|
NRIX |
Nurix Therapeutics, Inc. |
1.62B |
0.17% |
|
|
|
|
|
22.82 |
0.77% |
88.06% |
20.80% |
---|
BCRX |
BioCryst Pharmaceuticals, Inc. |
1.55B |
0.17% |
|
|
|
|
|
7.47 |
2.26% |
50.80% |
12.56% |
---|
HROW |
Harrow Health, Inc. |
1.56B |
0.17% |
|
|
|
|
|
43.71 |
2.99% |
62.67% |
14.88% |
---|
NTLA |
Intellia Therapeutics, Inc. |
1.44B |
0.17% |
|
|
|
|
|
14.10 |
7.43% |
82.03% |
58.88% |
---|
NVAX |
Novavax, Inc. |
1.30B |
0.16% |
|
|
|
|
|
8.12 |
0.74% |
73.84% |
30.30% |
---|
SNDX |
Syndax Pharmaceuticals, Inc. |
1.35B |
0.16% |
|
|
|
|
|
15.81 |
-0.91% |
69.74% |
45.36% |
---|
ZLAB |
Zai Lab Limited |
2.76B |
0.16% |
|
|
|
|
|
25.72 |
-1.94% |
67.78% |
22.32% |
---|
RCKT |
Rocket Pharmaceuticals, Inc. |
1.19B |
0.16% |
|
|
|
|
|
13.04 |
0.00% |
83.32% |
63.52% |
---|